Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
- GPCR News
- Jul 1, 2022
- 1 min read
Updated: Aug 18, 2022
July 2022
"Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical space and precision-engineer therapeutics with enhanced potency and tailored signaling against an undrugged GPCR target.

Comentarios